BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cox MJ, Loman N, Bogaert D, O'Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe 2020;1:e11. [PMID: 32835323 DOI: 10.1016/S2666-5247(20)30009-4] [Cited by in Crossref: 136] [Cited by in F6Publishing: 80] [Article Influence: 68.0] [Reference Citation Analysis]
Number Citing Articles
1 Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622-9. [PMID: 32711058 DOI: 10.1016/j.cmi.2020.07.016] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 125.0] [Reference Citation Analysis]
2 Pacheco GA, Gálvez NMS, Soto JA, Andrade CA, Kalergis AM. Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus. Microorganisms 2021;9:1293. [PMID: 34199284 DOI: 10.3390/microorganisms9061293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control 2020;15:Doc35. [PMID: 33391970 DOI: 10.3205/dgkh000370] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Chaudhry R, Sreenath K, Batra P, Vinayaraj EV, Rathor N, Saikiran K, Aravindan A, Singh V, Brijwal M, Soneja M, Verma N, Subramanium R, Singh UB, Guleria R. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol 2022;94:303-9. [PMID: 34491594 DOI: 10.1002/jmv.27324] [Reference Citation Analysis]
5 Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis 2021. [PMID: 33733394 DOI: 10.1007/s10096-021-04213-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ashiru-Oredope D, Kerr F, Hughes S, Urch J, Lanzman M, Yau T, Cockburn A, Patel R, Sheikh A, Gormley C, Chavda A, Vaghela T, Phillips C, Reid N, Brady A. Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom. Antibiotics (Basel) 2021;10:110. [PMID: 33498716 DOI: 10.3390/antibiotics10020110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Singh V, Upadhyay P, Reddy J, Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int J Infect Dis 2021;105:617-20. [PMID: 33640570 DOI: 10.1016/j.ijid.2021.02.087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
8 Charalampous T, Alcolea-Medina A, Snell LB, Williams TGS, Batra R, Alder C, Telatin A, Camporota L, Meadows CIS, Wyncoll D, Barrett NA, Hemsley CJ, Bryan L, Newsholme W, Boyd SE, Green A, Mahadeva U, Patel A, Cliff PR, Page AJ, O'Grady J, Edgeworth JD. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units. Genome Med 2021;13:182. [PMID: 34784976 DOI: 10.1186/s13073-021-00991-y] [Reference Citation Analysis]
9 Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Mostafa A, Kandeil A, A M M Elshaier Y, Kutkat O, Moatasim Y, Rashad AA, Shehata M, Gomaa MR, Mahrous N, Mahmoud SH, GabAllah M, Abbas H, Taweel AE, Kayed AE, Kamel MN, Sayes ME, Mahmoud DB, El-Shesheny R, Kayali G, Ali MA. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel) 2020;13:E443. [PMID: 33291642 DOI: 10.3390/ph13120443] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
11 Al Lawati R, Al Busaidi N, Al Umairi R, Al Busaidy M, Al Naabi HH, Khamis F. COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection. Oman Med J 2021;36:e298. [PMID: 34631157 DOI: 10.5001/omj.2022.23] [Reference Citation Analysis]
12 Mazzariol A, Benini A, Unali I, Nocini R, Smania M, Bertoncelli A, De Sanctis F, Ugel S, Donadello K, Polati E, Gibellini D. Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation. Front Cell Infect Microbiol 2021;11:683409. [PMID: 34458159 DOI: 10.3389/fcimb.2021.683409] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Peci A, Tran V, Guthrie JL, Li Y, Nelson P, Schwartz KL, Eshaghi A, Buchan SA, Gubbay JB. Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada. Viruses 2021;13:130. [PMID: 33477649 DOI: 10.3390/v13010130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
14 Olwal CO, Nganyewo NN, Tapela K, Djomkam Zune AL, Owoicho O, Bediako Y, Duodu S. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 2021;12:602848. [PMID: 33613574 DOI: 10.3389/fimmu.2021.602848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
15 Saeed NK, Al-Khawaja S, Alsalman J, Almusawi S, Albalooshi NA, Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J Virol 2021; 10(4): 168-181 [PMID: 34367932 DOI: 10.5501/wjv.v10.i4.168] [Reference Citation Analysis]
16 Hossain MR, Sarmin M, Rahman H, Shahrin L, Nyma Z, Ahmed T, Chisti MJ. SARS-CoV-2 and dengue virus coinfection in an adult with beta-thalassemia (trait): A case report from Bangladesh with literature review. Heliyon 2021;7:e08229. [PMID: 34693067 DOI: 10.1016/j.heliyon.2021.e08229] [Reference Citation Analysis]
17 Townsend L, Hughes G, Kerr C, Kelly M, O'Connor R, Sweeney E, Doyle C, O'Riordan R, Bergin C, Bannan C. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC Antimicrob Resist 2020;2:dlaa071. [PMID: 32864608 DOI: 10.1093/jacamr/dlaa071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
18 Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer APS, Daubenberger C, Brentani A. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med 2020:bmjebm-2020-111549. [PMID: 33310766 DOI: 10.1136/bmjebm-2020-111549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
19 Campisi G, Bizzoca ME, Lo Muzio L. COVID-19 and periodontitis: reflecting on a possible association. Head Face Med 2021;17:16. [PMID: 33975613 DOI: 10.1186/s13005-021-00267-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ting M, Suzuki JB. SARS-CoV-2: Overview and Its Impact on Oral Health. Biomedicines 2021;9:1690. [PMID: 34829919 DOI: 10.3390/biomedicines9111690] [Reference Citation Analysis]
21 Natto ZS, Afeef M, Khalil D, Kutubaldin D, Dehaithem M, Alzahrani A, Ashi H. Characteristics of Oral Manifestations in Symptomatic Non-Hospitalized COVID-19 Patients: A Cross-Sectional Study on a Sample of the Saudi Population. Int J Gen Med 2021;14:9547-53. [PMID: 34916836 DOI: 10.2147/IJGM.S331611] [Reference Citation Analysis]
22 Gregoire E, Pirotte BF, Moerman F, Altdorfer A, Gaspard L, Firre E, Moonen M, Fraipont V, Ernst M, Darcis G. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study. Pathogens 2021;10:1370. [PMID: 34832526 DOI: 10.3390/pathogens10111370] [Reference Citation Analysis]
23 Sheoran P, Tiwari SK. Synergistically-acting Enterocin LD3 and Plantaricin LD4 Against Gram-Positive and Gram-Negative Pathogenic Bacteria. Probiotics Antimicrob Proteins 2021;13:542-54. [PMID: 32918678 DOI: 10.1007/s12602-020-09708-w] [Reference Citation Analysis]
24 Aurilio C, Sansone P, Paladini A, Barbarisi M, Coppolino F, Pota V, Pace MC. Multidrug Resistence Prevalence in COVID Area. Life (Basel) 2021;11:601. [PMID: 34201519 DOI: 10.3390/life11070601] [Reference Citation Analysis]
25 Gao CA, Bailey JI, Walter JM, Coleman JM, Malsin ES, Argento AC, Prickett MH, Wunderink RG, Smith SB. Bronchoscopy on Intubated Patients with COVID-19 Is Associated with Low Infectious Risk to Operators. Ann Am Thorac Soc 2021;18:1243-6. [PMID: 33448892 DOI: 10.1513/AnnalsATS.202009-1225RL] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
26 Scherger S, Henao-Martínez A, Franco-Paredes C, Shapiro L. Rethinking interleukin-6 blockade for treatment of COVID-19. Med Hypotheses 2020;144:110053. [PMID: 32758889 DOI: 10.1016/j.mehy.2020.110053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
27 Tachalov VV, Orekhova LY, Kudryavtseva TV, Loboda ES, Pachkoriia MG, Berezkina IV, Golubnitschaja O. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach. EPMA J 2021;:1-12. [PMID: 33897916 DOI: 10.1007/s13167-021-00240-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, Delmonte OM, Bansal N, Failla L, Sottini A, Quiros-Roldan E, Han KL, Sellers BA, Cheung F, Sparks R, Chun TW, Moir S, Lionakis MS, Rossi C, Su HC, Kuhns DB, Cohen JI, Notarangelo LD, Tsang JS; NIAID COVID Consortium., COVID Clinicians. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 2021;184:1836-1857.e22. [PMID: 33713619 DOI: 10.1016/j.cell.2021.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
29 Mohapatra RK, Dhama K, Mishra S, Sarangi AK, Kandi V, Tiwari R, Pintilie L. The microbiota-related coinfections in COVID-19 patients: a real challenge. Beni Suef Univ J Basic Appl Sci 2021;10:47. [PMID: 34458380 DOI: 10.1186/s43088-021-00134-7] [Reference Citation Analysis]
30 Comber SDW, Upton M, Lewin S, Powell N, Hutchinson TH. COVID-19, antibiotics and One Health: a UK environmental risk assessment. J Antimicrob Chemother 2020;75:3411-2. [PMID: 32785691 DOI: 10.1093/jac/dkaa338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 He F, Xia X, Nie D, Yang H, Jiang Y, Huo X, Guo F, Fang B, Hu B, Jiang H, Zhan F, Lv J. Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients. Diagn Microbiol Infect Dis 2020;98:115199. [PMID: 32979617 DOI: 10.1016/j.diagmicrobio.2020.115199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Ali AS, ASattar MA, Karim S, Kutbi D, Aljohani H, Bakhshwin D, Alsieni M, Alkreathy HM. Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19. Arab J Chem 2021;14:102983. [PMID: 34909062 DOI: 10.1016/j.arabjc.2020.102983] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Rangel K, Chagas TPG, De-Simone SG. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. Pathogens 2021;10:1006. [PMID: 34451470 DOI: 10.3390/pathogens10081006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 De Santis V, Corona A, Vitale D, Nencini C, Potalivo A, Prete A, Zani G, Malfatto A, Tritapepe L, Taddei S, Locatelli A, Sambri V, Fusari M, Singer M. Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study. Infection 2021. [PMID: 34260055 DOI: 10.1007/s15010-021-01661-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Xiang Z, Koo H, Chen Q, Zhou X, Liu Y, Simon-Soro A. Potential implications of SARS-CoV-2 oral infection in the host microbiota. J Oral Microbiol 2020;13:1853451. [PMID: 33312449 DOI: 10.1080/20002297.2020.1853451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
36 Tang ML, Li YQ, Chen X, Lin H, Jiang ZC, Gu DL, Chen X, Tang CX, Xie ZQ. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China. Med Sci Monit 2021;27:e929783. [PMID: 33388738 DOI: 10.12659/MSM.929783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Romero MP, Alves F, Stringasci MD, Buzzá HH, Ciol H, Inada NM, Bagnato VS. One-Pot Microwave-Assisted Synthesis of Carbon Dots and in vivo and in vitro Antimicrobial Photodynamic Applications. Front Microbiol 2021;12:662149. [PMID: 34234756 DOI: 10.3389/fmicb.2021.662149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mayi BS, Mainville M, Altaf R, Lanspa M, Vaniawala S, Ollerhead TA, Raja A. A Crucial Role for Antimicrobial Stewardship in the Midst of COVID-19. J Microbiol Biol Educ 2021;22. [DOI: 10.1128/jmbe.v22i1.2285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Bakovic A, Risner K, Bhalla N, Alem F, Chang TL, Weston WK, Harness JA, Narayanan A. Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture. Viruses 2021;13:271. [PMID: 33572467 DOI: 10.3390/v13020271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
40 Sohal S, Rodriguez-Nava G, Khabbaz R, Chaudry S, Musurakis C, Chitrakar S, Chundi VV, Friedman HJ. SARS-CoV2 and Co-Infections: A Review of Two Cases. Case Rep Infect Dis 2020;2020:8882348. [PMID: 33014484 DOI: 10.1155/2020/8882348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Srinivasan M. Taste Dysfunction and Long COVID-19. Front Cell Infect Microbiol 2021;11:716563. [PMID: 34336725 DOI: 10.3389/fcimb.2021.716563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Colliers A, De Man J, Adriaenssens N, Verhoeven V, Anthierens S, De Loof H, Philips H, Coenen S, Morreel S. Antibiotic Prescribing Trends in Belgian Out-of-Hours Primary Care during the COVID-19 Pandemic: Observational Study Using Routinely Collected Health Data. Antibiotics (Basel) 2021;10:1488. [PMID: 34943701 DOI: 10.3390/antibiotics10121488] [Reference Citation Analysis]
43 Thakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, Saxena SK, Devi M, Yadav D, Mehariya S. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med 2021;10:446. [PMID: 33498861 DOI: 10.3390/jcm10030446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
44 Pickens CO, Gao CA, Cuttica M, Smith SB, Pesce L, Grant R, Kang M, Morales-Nebreda L, Bavishi AA, Arnold J, Pawlowski A, Qi C, Budinger GS, Singer BD, Wunderink RG. Bacterial superinfection pneumonia in SARS-CoV-2 respiratory failure. medRxiv 2021:2021. [PMID: 33469593 DOI: 10.1101/2021.01.12.20248588] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
45 Liu TFD, Philippou E, Kolokotroni O, Siakallis G, Rahima K, Constantinou C. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review. Infection 2021. [PMID: 34671922 DOI: 10.1007/s15010-021-01715-5] [Reference Citation Analysis]
46 Al-Hatmi AMS, Mohsin J, Al-Huraizi A, Khamis F. COVID-19 associated invasive candidiasis. J Infect 2021;82:e45-6. [PMID: 32771402 DOI: 10.1016/j.jinf.2020.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
47 Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021;133:110947. [PMID: 33197765 DOI: 10.1016/j.biopha.2020.110947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
48 Kitsios GD, Bain W, Al-Yousif N, Duttagupta R, Ahmed AA, McVerry BJ, Morris A. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19. Respir Res 2021;22:24. [PMID: 33472605 DOI: 10.1186/s12931-021-01623-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Pickens CO, Gao CA, Cuttica MJ, Smith SB, Pesce LL, Grant RA, Kang M, Morales-Nebreda L, Bavishi AA, Arnold JM, Pawlowski A, Qi C, Budinger GRS, Singer BD, Wunderink RG; NU COVID Investigators. Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. Am J Respir Crit Care Med 2021;204:921-32. [PMID: 34409924 DOI: 10.1164/rccm.202106-1354OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
50 Steenwyk JL, Mead ME, de Castro PA, Valero C, Damasio A, Dos Santos RAC, Labella AL, Li Y, Knowles SL, Raja HA, Oberlies NH, Zhou X, Cornely OA, Fuchs F, Koehler P, Goldman GH, Rokas A. Genomic and phenotypic analysis of COVID-19-associated pulmonary aspergillosis isolates of Aspergillus fumigatus. bioRxiv 2020:2020. [PMID: 33173866 DOI: 10.1101/2020.11.06.371971] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chaudhry R, Sreenath K, Vinayaraj EV, Sahoo B, Vishnu Narayanan MR, Kiran KVPS, Batra P, Rathor N, Singh S, Mohan A, Bhatnagar S. Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report. Access Microbiol 2021;3:000212. [PMID: 34151164 DOI: 10.1099/acmi.0.000212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, Dashtbin S, Jalalifar S, Mohammadzadeh R, Teimoori A, Tari K, Salari M, Ghiasvand S, Kazemi S, Yousefimashouf R, Keyvani H, Karampoor S. Bacterial co-infections with SARS-CoV-2. IUBMB Life 2020;72:2097-111. [PMID: 32770825 DOI: 10.1002/iub.2356] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
53 Hossain KS, Hossain MG, Moni A, Rahman MM, Rahman UH, Alam M, Kundu S, Rahman MM, Hannan MA, Uddin MJ. Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises. Heliyon 2020;6:e05798. [PMID: 33363261 DOI: 10.1016/j.heliyon.2020.e05798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
54 Kolenda C, Ranc AG, Boisset S, Caspar Y, Carricajo A, Souche A, Dauwalder O, Verhoeven PO, Vandenesch F, Laurent F. Assessment of Respiratory Bacterial Coinfections Among Severe Acute Respiratory Syndrome Coronavirus 2-Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire, FilmArray Pneumonia Panel Plus Assay. Open Forum Infect Dis 2020;7:ofaa484. [PMID: 33204762 DOI: 10.1093/ofid/ofaa484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
55 Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021;13:5. [PMID: 33894790 DOI: 10.1186/s41479-021-00083-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
56 Bhattacharya C, Chowdhury D, Ahmed N, Özgür S, Bhattacharya B, Mridha SK, Bhattacharyya M. The nature, cause and consequence of COVID-19 panic among social media users in India. Soc Netw Anal Min 2021;11:53. [PMID: 34122667 DOI: 10.1007/s13278-021-00750-2] [Reference Citation Analysis]
57 Bhargava K, Nath G, Bhargava A, Aseri GK, Jain N. Phage therapeutics: from promises to practices and prospectives. Appl Microbiol Biotechnol 2021;105:9047-67. [PMID: 34821965 DOI: 10.1007/s00253-021-11695-z] [Reference Citation Analysis]
58 Decker AM, Kapila YL, Wang HL. The psychobiological links between chronic stress-related diseases, periodontal/peri-implant diseases, and wound healing. Periodontol 2000 2021;87:94-106. [PMID: 34463997 DOI: 10.1111/prd.12381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Rhouma M, Tessier M, Aenishaenslin C, Sanders P, Carabin H. Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance? Antibiotics (Basel) 2021;10:464. [PMID: 33923886 DOI: 10.3390/antibiotics10040464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Gallacher SD, Seaton A. Meningococcal meningitis and COVID-19 co-infection. BMJ Case Rep 2020;13:e237366. [PMID: 32843469 DOI: 10.1136/bcr-2020-237366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Im H, Ser J, Sim U, Cho H. Promising Expectations for Pneumococcal Vaccination during COVID-19. Vaccines (Basel) 2021;9:1507. [PMID: 34960253 DOI: 10.3390/vaccines9121507] [Reference Citation Analysis]
62 Pérez-Lazo G, Silva-Caso W, Del Valle-Mendoza J, Morales-Moreno A, Ballena-López J, Soto-Febres F, Martins-Luna J, Carrillo-Ng H, Del Valle LJ, Kym S, Aguilar-Luis MA, Peña-Tuesta I, Tinco-Valdez C, Illescas LR. Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics. Antibiotics (Basel) 2021;10:1358. [PMID: 34827296 DOI: 10.3390/antibiotics10111358] [Reference Citation Analysis]
63 Ong CCH, Farhanah S, Linn KZ, Tang YW, Poon CY, Lim AY, Tan HR, Binte Hamed NH, Huan X, Puah SH, Ho BCH, Soon MML, Ang BSP, Vasoo S, Chan M, Leo YS, Ng OT, Marimuthu K. Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data. Antimicrob Resist Infect Control 2021;10:119. [PMID: 34384493 DOI: 10.1186/s13756-021-00988-7] [Reference Citation Analysis]
64 Neumann J, Prezzemolo T, Vanderbeke L, Roca CP, Gerbaux M, Janssens S, Willemsen M, Burton O, Van Mol P, Van Herck Y, Wauters J, Wauters E, Liston A, Humblet-Baron S; CONTAGIOUS co‐authors. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19. Clin Transl Immunology 2020;9:e1204. [PMID: 33209300 DOI: 10.1002/cti2.1204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
65 Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, Kim G, Kim HS, Lee MS, Lee J, Hur JA, Chin BS, Eom JS, Baek HJ; Korean College of Rheumatology working group. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med 2020;35:1317-32. [PMID: 32972125 DOI: 10.3904/kjim.2020.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Fischer N, Dauby N, Bossuyt N, Reynders M, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Barbezange C, Subissi L. Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study. Lancet Microbe 2021;2:e105-14. [PMID: 33937883 DOI: 10.1016/S2666-5247(20)30221-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
67 Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control 2021;10:21. [PMID: 33514424 DOI: 10.1186/s13756-021-00893-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
68 Tellapragada C, Giske CG. The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients. Eur J Clin Microbiol Infect Dis 2021;40:2479-85. [PMID: 33661410 DOI: 10.1007/s10096-021-04194-6] [Reference Citation Analysis]
69 Kubin CJ, McConville TH, Dietz D, Zucker J, May M, Nelson B, Istorico E, Bartram L, Small-Saunders J, Sobieszczyk ME, Gomez-Simmonds A, Uhlemann AC. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis 2021;8:ofab201. [PMID: 34099978 DOI: 10.1093/ofid/ofab201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
70 Chen C, Li J, Di L, Jing Q, Du P, Song C, Li J, Li Q, Cao Y, Xie XS, Wu AR, Zeng H, Huang Y, Wang J. MINERVA: A Facile Strategy for SARS-CoV-2 Whole-Genome Deep Sequencing of Clinical Samples. Mol Cell 2020;80:1123-1134.e4. [PMID: 33290743 DOI: 10.1016/j.molcel.2020.11.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
71 Massey BW, Jayathilake K, Meltzer HY. Respiratory Microbial Co-infection With SARS-CoV-2. Front Microbiol 2020;11:2079. [PMID: 32983056 DOI: 10.3389/fmicb.2020.02079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
72 Gesesew HA, Koye DN, Fetene DM, Woldegiorgis M, Kinfu Y, Geleto AB, Melaku YA, Mohammed H, Alene KA, Awoke MA, Birhanu MM, Gebremedhin AT, Gelaw YA, Shifti DM, Muluneh MD, Tegegne TK, Abrha S, Aregay AF, Ayalew MB, Gebre AK, Gebremariam KT, Gebremedhin T, Gebremichael L, Leshargie CT, Kibret GD, Meazaw MW, Mekonnen AB, Tekle DY, Tesema AG, Tesfay FH, Tesfaye W, Wubishet BL, Dachew BA, Adane AA. Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review. BMJ Open 2021;11:e044618. [PMID: 33602714 DOI: 10.1136/bmjopen-2020-044618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
73 Petersen FC, Dahle UR, Nicolau B, Casals-Pascual C. COVID-19: Looking Into the Overlooked. Front Mol Biosci 2020;7:165. [PMID: 32850958 DOI: 10.3389/fmolb.2020.00165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ramadan HK, Mahmoud MA, Aburahma MZ, Elkhawaga AA, El-Mokhtar MA, Sayed IM, Hosni A, Hassany SM, Medhat MA. Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt. Infect Drug Resist 2020;13:3409-22. [PMID: 33116660 DOI: 10.2147/IDR.S272605] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
75 Zirpe KG, Tiwari AM, Gurav SK, Deshmukh AM, Suryawanshi PB, Wankhede PP, Kapse US, Bhoyar AP, Khan AZ, Malhotra RV, Kusalkar PH, Chavan KJ, Naik SA, Bhalke RB, Bhosale NN, Makhija SV, Kuchimanchi VN, Jadhav AS, Deshmukh KR, Kulkarni GS. Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Indian J Crit Care Med 2021;25:493-8. [PMID: 34177166 DOI: 10.5005/jp-journals-10071-23816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Zuo T, Wu X, Wen W, Lan P. Gut Microbiome Alterations in COVID-19. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00206-0. [PMID: 34560321 DOI: 10.1016/j.gpb.2021.09.004] [Reference Citation Analysis]
77 Fontana C, Favaro M, Minelli S, Bossa MC, Altieri A. Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test. Sci Rep 2021;11:16355. [PMID: 34381118 DOI: 10.1038/s41598-021-95772-3] [Reference Citation Analysis]
78 Gaibani P, D'Amico F, Bartoletti M, Lombardo D, Rampelli S, Fornaro G, Coladonato S, Siniscalchi A, Re MC, Viale P, Brigidi P, Turroni S, Giannella M. The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol 2021;11:670424. [PMID: 34268136 DOI: 10.3389/fcimb.2021.670424] [Reference Citation Analysis]
79 Subramanya SH, Czyż DM, Acharya KP, Humphreys H. The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship. Virusdisease 2021;:1-8. [PMID: 34056051 DOI: 10.1007/s13337-021-00695-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Fu H, Gray KA. The key to maximizing the benefits of antimicrobial and self-cleaning coatings is to fully determine their risks. Current Opinion in Chemical Engineering 2021;34:100761. [DOI: 10.1016/j.coche.2021.100761] [Reference Citation Analysis]
81 Chalker VJ, Adler H, Ball R, Naik F, Day J, Afshar B, Amin AK. Fatal Co-infections with SARS-CoV-2 and Legionella pneumophila, England. Emerg Infect Dis 2021;27:2950-2. [PMID: 34670660 DOI: 10.3201/eid2711.204121] [Reference Citation Analysis]
82 Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, Egoryan G, Friedman HJ. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center. Med Sci Monit 2020;26:e928754. [PMID: 33188161 DOI: 10.12659/MSM.928754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Kamel AHM, Basuoni A, Salem ZA, AbuBakr N. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. Br Dent J 2021. [PMID: 33627848 DOI: 10.1038/s41415-021-2656-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, Cally R, Logre E, Fraissé M, Mentec H, Plantefève G. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 2020;10:119. [PMID: 32894364 DOI: 10.1186/s13613-020-00736-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 32.5] [Reference Citation Analysis]
85 Nainu F, Permana AD, Djide NJN, Anjani QK, Utami RN, Rumata NR, Zhang J, Emran TB, Simal-Gandara J. Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges. Antibiotics (Basel) 2021;10:981. [PMID: 34439031 DOI: 10.3390/antibiotics10080981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
86 Farjana M, Moni A, Sohag AAM, Hasan A, Hannan MA, Hossain MG, Uddin MJ. Repositioning Vitamin C as a Promising Option to Alleviate Complications associated with COVID-19. Infect Chemother 2020;52:461-77. [PMID: 33263242 DOI: 10.3947/ic.2020.52.4.461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, Chan PKS, Ng SC. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology 2020;159:1302-1310.e5. [PMID: 32598884 DOI: 10.1053/j.gastro.2020.06.048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 70] [Article Influence: 27.0] [Reference Citation Analysis]
88 Casillas Santana MA, Arreguín Cano JA, Dib Kanán A, Dipp Velázquez FA, Munguía PDCS, Martínez Castañón GA, Castillo Silva BE, Sámano Valencia C, Salas Orozco MF. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis. Medicina (Kaunas) 2021;57:493. [PMID: 34068221 DOI: 10.3390/medicina57050493] [Reference Citation Analysis]
89 Hoogenkamp MA, Brandt BW, Laheij AMGA, de Soet JJ, Crielaard W. The microbiological load and microbiome of the Dutch dental unit; 'please, hold your breath'. Water Res 2021;200:117205. [PMID: 34058484 DOI: 10.1016/j.watres.2021.117205] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
91 Baarz BR, Rink L. Rebalancing the unbalanced aged immune system - A special focus on zinc. Ageing Res Rev 2021;74:101541. [PMID: 34915196 DOI: 10.1016/j.arr.2021.101541] [Reference Citation Analysis]
92 El Tabaa MM, El Tabaa MM. New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19. Eur J Pharmacol 2020;889:173615. [PMID: 33011243 DOI: 10.1016/j.ejphar.2020.173615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
93 McCreath G, Whitfield PD, Roe AJ, Watson MJ, Sim MAB. A Metabolomics approach for the diagnosis Of SecondAry InfeCtions in COVID-19 (MOSAIC): a study protocol. BMC Infect Dis 2021;21:1204. [PMID: 34856937 DOI: 10.1186/s12879-021-06832-y] [Reference Citation Analysis]
94 Sterenczak KA, Barrantes I, Stahnke T, Stachs O, Fuellen G, Undre N. Co-infections: testing macrolides for added benefit in patients with COVID-19. Lancet Microbe 2020;1:e313. [PMID: 33521730 DOI: 10.1016/S2666-5247(20)30170-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Afshinnekoo E, Bhattacharya C, Burguete-García A, Castro-Nallar E, Deng Y, Desnues C, Dias-Neto E, Elhaik E, Iraola G, Jang S, Łabaj PP, Mason CE, Nagarajan N, Poulsen M, Prithiviraj B, Siam R, Shi T, Suzuki H, Werner J, Zambrano MM, Bhattacharyya M; MetaSUB Consortium. COVID-19 drug practices risk antimicrobial resistance evolution. Lancet Microbe 2021;2:e135-6. [PMID: 33655229 DOI: 10.1016/S2666-5247(21)00039-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
96 van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine 2020;61:103044. [PMID: 33039713 DOI: 10.1016/j.ebiom.2020.103044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Kordalewska M, Guerrero KD, Garcia-Rubio R, Jiménez-Ortigosa C, Mediavilla JR, Cunningham MH, Hollis F, Hong T, Chow KF, Kreiswirth BN, Perlin DS. Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients. J Fungi (Basel) 2021;7:552. [PMID: 34356931 DOI: 10.3390/jof7070552] [Reference Citation Analysis]
98 Bashir A, Abdullah MS, Momin NR, Chong PL, Asli R, Ivan BM, Chong VH. Prevalence of primary bacterial co-infections among patients with COVID-19 in Brunei Darussalam. Western Pac Surveill Response J 2021;12:65-70. [PMID: 34703637 DOI: 10.5365/wpsar.2021.12.3.856] [Reference Citation Analysis]
99 Chávez-Reyes J, Escárcega-González CE, Chavira-Suárez E, León-Buitimea A, Vázquez-León P, Morones-Ramírez JR, Villalón CM, Quintanar-Stephano A, Marichal-Cancino BA. Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia. Front Public Health 2021;9:559595. [PMID: 33665182 DOI: 10.3389/fpubh.2021.559595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Induri SNR, Chun YC, Chun JC, Fleisher KE, Glickman RS, Xu F, Ioannidou E, Li X, Saxena D. Protective Measures against COVID-19: Dental Practice and Infection Control. Healthcare (Basel) 2021;9:679. [PMID: 34200036 DOI: 10.3390/healthcare9060679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]